Aytu Biopharma, Inc. (AYTU)
2.14
+0.02
(+0.94%)
USD |
NASDAQ |
Sep 21, 16:00
2.14
0.00 (0.00%)
After-Hours: 20:00
Aytu Biopharma Total Liabilities (Quarterly) : 76.55M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 76.55M |
| December 31, 2025 | 107.80M |
| September 30, 2025 | 101.82M |
| June 30, 2025 | 105.46M |
| March 31, 2025 | 89.30M |
| December 31, 2024 | 85.46M |
| September 30, 2024 | 86.00M |
| June 30, 2024 | 91.14M |
| March 31, 2024 | 98.09M |
| December 31, 2023 | 98.40M |
| September 30, 2023 | 100.72M |
| June 30, 2023 | 98.48M |
| March 31, 2023 | 106.30M |
| December 31, 2022 | 95.62M |
| September 30, 2022 | 101.65M |
| June 30, 2022 | 93.32M |
| March 31, 2022 | 107.68M |
| December 31, 2021 | 118.29M |
| September 30, 2021 | 116.23M |
| June 30, 2021 | 139.01M |
| March 31, 2021 | 128.41M |
| December 31, 2020 | 54.05M |
| September 30, 2020 | 50.21M |
| June 30, 2020 | 60.08M |
| March 31, 2020 | 73.25M |
| Date | Value |
|---|---|
| December 31, 2019 | 57.39M |
| September 30, 2019 | 28.70M |
| June 30, 2019 | 27.63M |
| March 31, 2019 | 22.30M |
| December 31, 2018 | 22.50M |
| September 30, 2018 | 7.855M |
| June 30, 2018 | 7.636M |
| March 31, 2018 | 10.62M |
| December 31, 2017 | 15.83M |
| September 30, 2017 | 14.89M |
| June 30, 2017 | 11.00M |
| March 31, 2017 | 7.395M |
| December 31, 2016 | 11.06M |
| September 30, 2016 | 13.01M |
| June 30, 2016 | 14.26M |
| March 31, 2016 | 4.420M |
| December 31, 2015 | 9.151M |
| September 30, 2015 | 7.951M |
| June 30, 2015 | |
| March 31, 2015 | 9.650M |
| February 28, 2015 | 0.0609M |
| November 30, 2014 | 0.0552M |
| August 31, 2014 | 0.0505M |
| May 31, 2014 | 0.0495M |
| February 28, 2014 | 0.1534M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 111.69M |
| Shareholders Equity (Quarterly) | 35.14M |
| Debt to Equity Ratio | 0.6527 |
| Current Ratio | 1.123 |
| Net Debt Paydown Yield | -3.96% |